News

The Indian medical equipments market is projected at INR57.5 with a growth rate of 23% expected in the coming years. The market for medical supplies and disposables is

Wyeth has received positive recommendations from the European Committee for Medicinal Products for Human Use (CHMP) for two recent submissions relating to Enbrel (etanercept). It’s a tumour necrosis

Synthetech has announced financial results for its fiscal fourth quarter and fiscal year, which ended March 31, 2009. For the fourth quarter ended March 31, 2009, revenue was

A patent appeals board had ruled in favor of Affymetrix, as did the U.S. District Court for the Northern District of California. But the U.S. Court of Appeals

Eli Lilly has resubmitted its supplemental New Drug Application (sNDA) for Cymbalta (duloxetine HCl) for the management of chronic pain, to the FDA. The resubmission is based on

CombiMatrix has announced that the validation study performed by its wholly-owned subsidiary, Combimatrix Molecular Diagnostics (CMDX), in collaboration with the Department of Pathology at the University of Texas

Genta has declared preliminary results showing a high objective response rate and potentially extended survival in an ongoing pilot study. The trial incorporates the company’s lead oncology product,

Affymax has announced that the independent Data Monitoring Committee (DMC), which provides oversight for the Phase-III program for Hematid, has completed another review. DMC has informed the company

Advaxis has received the FDA letter denying the company’s request for Orphan Drug Designation (ODD) for the use of Adxs11-001 in invasive cervix cancer. FDA stated that their